Background Korea’s rapidly aging population has experienced a sharp rise in the prevalence of dementia. Patients with Alzheimer’s disease (AD), which is estimated to be about three-quarters of all patients with dementia, tend to have higher mortality rates compared with patients without Alzheimer’s disease. In this study, a survival analysis of patients with AD was conducted in order to provide knowledge to those who provide medical care to these patients.
Methods Data on individuals over 65 years old in 2004 were extracted from the Korean National Health Insurance Services’ Senior Cohort database (2002–2013). The subjects were 209,254 patients, including 2,695 who were first diagnosed with AD (the AD group) and 206,559 that had not been diagnosed with the disease (non-AD group). To investigate the independent effect of AD on survival, the Cox proportional-hazards model, hazard ratios (confidence interval of 95%), and the Kaplan-Meier method were used.
Results Mean survival time in the AD group was 5.3±3.3 years, which was about 2.5 years shorter than that in the non-AD group (7.8±2.4 years). The mortality rate in the AD group (66.3%) was higher than that in the non-AD group (26.3%). The adjusted hazard ratio in the AD group was 2.5 and, therefore, it was found that the AD group had a 2.5-fold higher risk of death than the non-AD group.
Conclusion Overall, AD has a large, independent impact on survival. Survival time was shorter, and the mortality rate and risk were generally higher in the AD group, compared with the non-AD group.
Citations
Citations to this article as recorded by
Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review Purnima Rani Debi, Hrishika Barua, Mirja Kaizer Ahmmed, Shuva Bhowmik Marine Drugs.2025; 23(8): 310. CrossRef
Clinical profile and survival analysis of Alzheimer’s disease patients in a Brazilian cohort Elisa de Melo Queiroz, Christian Marques Couto, Cláudio Antônio da Cruz Mecone, Waneska Souza Lima Macedo, Paulo Caramelli Neurological Sciences.2024; 45(1): 129. CrossRef
Survival After the Diagnosis of Mild‐to‐Moderate Alzheimer's Disease Dementia: A 15‐Year National Cohort Study in Taiwan Yu Sun, Chih‐Ching Liu, Chung‐Yi Li, Ming‐Jang Chiu International Journal of Geriatric Psychiatry.2024;[Epub] CrossRef
Collaborative Survival Analysis on Predicting Alzheimer’s Disease Progression Wanwan Xu, Selena Wang, Li Shen, Yize Zhao Statistics in Biosciences.2024;[Epub] CrossRef
Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance Khanh Linh Duong, Heeyoon Jung, Hyun-kyoung Lee, Young Jin Moon, Sang Ki Lee, Bo Ram Yang, Hwi-yeol Yun, Jung-woo Chae BMC Geriatrics.2024;[Epub] CrossRef
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES Rei Ono, Takashi Sakurai, Taiki Sugimoto, Kazuaki Uchida, Takeshi Nakagawa, Taiji Noguchi, Ayane Komatsu, Hidenori Arai, Tami Saito Journal of Alzheimer's Disease.2023; 92(2): 487. CrossRef
Infections among individuals with multiple sclerosis, Alzheimer’s disease and Parkinson’s disease Yihan Hu, Kejia Hu, Huan Song, Yudi Pawitan, Fredrik Piehl, Fang Fang Brain Communications.2023;[Epub] CrossRef
Independent effects of amyloid and vascular markers on long‐term functional outcomes: An 8‐year longitudinal study of subcortical vascular cognitive impairment Sung Hoon Kang, Sook‐young Woo, Seonwoo Kim, Jun Pyo Kim, Hyemin Jang, Seong‐Beom Koh, Duk L. Na, Hee Jin Kim, Sang Won Seo European Journal of Neurology.2022; 29(2): 413. CrossRef
Deep learning algorithm reveals probabilities of stage‐specific time to conversion in individuals with neurodegenerative disease LATE Xinxing Wu, Chong Peng, Peter T. Nelson, Qiang Cheng Alzheimer's & Dementia: Translational Research & Clinical Interventions.2022;[Epub] CrossRef
Time‐to‐event prediction using survival analysis methods for Alzheimer's disease progression Rahul Sharma, Harsh Anand, Youakim Badr, Robin G. Qiu Alzheimer's & Dementia: Translational Research & Clinical Interventions.2021;[Epub] CrossRef
Despite wide acceptance of the idea of 'evidence based medicine (EBM)', there is still a huge gap between evidence and clinical practice. Pre-appraised resources help clinicians find correct answers to clinical questions more easily and rapidly. It will briefly explain the concept and history of EBM. Frequently used pre-appraised resources like as systematic review, evidence based guidelines, health technology assessment, synopses, and clinical information database systems are also introduced.
Citations
Citations to this article as recorded by
Designing Digital Therapeutic Content Using Chronic Disease Data: A Focus on Improving Urinary Dysfunction Jungjo Na, Su Jin Kim, Yangmi Lim International Neurourology Journal.2023; 27(Suppl 2): S51. CrossRef
Analysis of Unstructured Data on Detecting of New Drug Indication of Atorvastatin Hwee-Soo Jeong, Gil-Won Kang, Woong Choi, Jong-Hyock Park, Kwang-Soo Shin, Young-Sung Suh Journal of Health Informatics and Statistics.2018; 43(4): 329. CrossRef
Research Trend of Nurses' Job Stress: A Comparative Study Yunjeong Yi, Bokim Lee Korean Journal of Occupational Health Nursing.2013; 22(1): 13. CrossRef
First
Prev
